nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Vinblastine—Vincristine—colon cancer	0.046	1	CbGdCrCtD
Bimatoprost—PTGER1—renal system—colon cancer	0.0352	0.134	CbGeAlD
Bimatoprost—Common cold—Fluorouracil—colon cancer	0.0333	0.0488	CcSEcCtD
Bimatoprost—PTGER3—smooth muscle tissue—colon cancer	0.0321	0.122	CbGeAlD
Bimatoprost—PTGER3—renal system—colon cancer	0.0309	0.118	CbGeAlD
Bimatoprost—PTGFR—smooth muscle tissue—colon cancer	0.0256	0.0977	CbGeAlD
Bimatoprost—PTGER3—digestive system—colon cancer	0.0253	0.0965	CbGeAlD
Bimatoprost—Punctate keratitis—Capecitabine—colon cancer	0.024	0.0352	CcSEcCtD
Bimatoprost—AKR1C3—smooth muscle tissue—colon cancer	0.0208	0.0794	CbGeAlD
Bimatoprost—Chronic obstructive pulmonary disease—Methotrexate—colon cancer	0.0158	0.0232	CcSEcCtD
Bimatoprost—Lacrimation—Irinotecan—colon cancer	0.0154	0.0226	CcSEcCtD
Bimatoprost—AKR1C3—bone marrow—colon cancer	0.0152	0.0578	CbGeAlD
Bimatoprost—PTGFR—liver—colon cancer	0.0151	0.0575	CbGeAlD
Bimatoprost—Lacrimation—Fluorouracil—colon cancer	0.0148	0.0216	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Fluorouracil—colon cancer	0.0146	0.0214	CcSEcCtD
Bimatoprost—AKR1C3—vagina—colon cancer	0.0145	0.0554	CbGeAlD
Bimatoprost—PTGER3—lymph node—colon cancer	0.0145	0.0551	CbGeAlD
Bimatoprost—Blepharitis—Fluorouracil—colon cancer	0.0141	0.0207	CcSEcCtD
Bimatoprost—AKR1C3—liver—colon cancer	0.0123	0.0467	CbGeAlD
Bimatoprost—PTGFR—lymph node—colon cancer	0.0116	0.0441	CbGeAlD
Bimatoprost—Stinging—Fluorouracil—colon cancer	0.0107	0.0157	CcSEcCtD
Bimatoprost—Hirsutism—Capecitabine—colon cancer	0.0104	0.0153	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Capecitabine—colon cancer	0.0102	0.015	CcSEcCtD
Bimatoprost—Eye irritation—Fluorouracil—colon cancer	0.0102	0.0149	CcSEcCtD
Bimatoprost—Cough increased—Irinotecan—colon cancer	0.0099	0.0145	CcSEcCtD
Bimatoprost—Lacrimation increased—Irinotecan—colon cancer	0.00983	0.0144	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—colon cancer	0.0096	1	CrCbGaD
Bimatoprost—Lacrimation increased—Fluorouracil—colon cancer	0.00942	0.0138	CcSEcCtD
Bimatoprost—AKR1C3—lymph node—colon cancer	0.0094	0.0358	CbGeAlD
Bimatoprost—Keratitis—Capecitabine—colon cancer	0.00935	0.0137	CcSEcCtD
Bimatoprost—Inflammation—Fluorouracil—colon cancer	0.00895	0.0131	CcSEcCtD
Bimatoprost—Photophobia—Fluorouracil—colon cancer	0.00815	0.012	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Methotrexate—colon cancer	0.00759	0.0111	CcSEcCtD
Bimatoprost—Eye irritation—Capecitabine—colon cancer	0.0071	0.0104	CcSEcCtD
Bimatoprost—Visual disturbance—Irinotecan—colon cancer	0.00694	0.0102	CcSEcCtD
Bimatoprost—Skin discolouration—Capecitabine—colon cancer	0.00672	0.00985	CcSEcCtD
Bimatoprost—Lacrimation increased—Capecitabine—colon cancer	0.00658	0.00965	CcSEcCtD
Bimatoprost—Burning sensation—Methotrexate—colon cancer	0.0065	0.00953	CcSEcCtD
Bimatoprost—Cataract—Capecitabine—colon cancer	0.00637	0.00934	CcSEcCtD
Bimatoprost—Inflammation—Capecitabine—colon cancer	0.00625	0.00917	CcSEcCtD
Bimatoprost—Dry skin—Fluorouracil—colon cancer	0.00578	0.00847	CcSEcCtD
Bimatoprost—Nasopharyngitis—Fluorouracil—colon cancer	0.00563	0.00826	CcSEcCtD
Bimatoprost—Dry eye—Capecitabine—colon cancer	0.0056	0.00822	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Irinotecan—colon cancer	0.00528	0.00775	CcSEcCtD
Bimatoprost—Depression—Vincristine—colon cancer	0.00519	0.00761	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00506	0.00742	CcSEcCtD
Bimatoprost—Skin discolouration—Methotrexate—colon cancer	0.005	0.00733	CcSEcCtD
Bimatoprost—Eye pain—Capecitabine—colon cancer	0.00488	0.00715	CcSEcCtD
Bimatoprost—Inflammation—Methotrexate—colon cancer	0.00466	0.00683	CcSEcCtD
Bimatoprost—Connective tissue disorder—Vincristine—colon cancer	0.00459	0.00673	CcSEcCtD
Bimatoprost—Rhinitis—Irinotecan—colon cancer	0.00456	0.00669	CcSEcCtD
Bimatoprost—Sinusitis—Fluorouracil—colon cancer	0.00456	0.00668	CcSEcCtD
Bimatoprost—Arthritis—Capecitabine—colon cancer	0.00453	0.00664	CcSEcCtD
Bimatoprost—Connective tissue disorder—Irinotecan—colon cancer	0.00447	0.00656	CcSEcCtD
Bimatoprost—Cystitis noninfective—Methotrexate—colon cancer	0.00441	0.00647	CcSEcCtD
Bimatoprost—Diplopia—Capecitabine—colon cancer	0.0044	0.00646	CcSEcCtD
Bimatoprost—Visual impairment—Irinotecan—colon cancer	0.00439	0.00643	CcSEcCtD
Bimatoprost—Rhinitis—Fluorouracil—colon cancer	0.00437	0.00641	CcSEcCtD
Bimatoprost—Cystitis—Methotrexate—colon cancer	0.00436	0.00639	CcSEcCtD
Bimatoprost—Pharyngitis—Fluorouracil—colon cancer	0.00433	0.00634	CcSEcCtD
Bimatoprost—Angiopathy—Vincristine—colon cancer	0.00424	0.00622	CcSEcCtD
Bimatoprost—Mediastinal disorder—Vincristine—colon cancer	0.00421	0.00618	CcSEcCtD
Bimatoprost—Angiopathy—Irinotecan—colon cancer	0.00413	0.00606	CcSEcCtD
Bimatoprost—Mediastinal disorder—Irinotecan—colon cancer	0.0041	0.00601	CcSEcCtD
Bimatoprost—Bladder pain—Methotrexate—colon cancer	0.00408	0.00599	CcSEcCtD
Bimatoprost—Liver function test abnormal—Capecitabine—colon cancer	0.00406	0.00596	CcSEcCtD
Bimatoprost—Dry skin—Capecitabine—colon cancer	0.00404	0.00592	CcSEcCtD
Bimatoprost—Nasopharyngitis—Capecitabine—colon cancer	0.00394	0.00577	CcSEcCtD
Bimatoprost—Asthma—Capecitabine—colon cancer	0.00381	0.00558	CcSEcCtD
Bimatoprost—Erythema—Fluorouracil—colon cancer	0.00379	0.00556	CcSEcCtD
Bimatoprost—Bronchitis—Capecitabine—colon cancer	0.00366	0.00537	CcSEcCtD
Bimatoprost—Vertigo—Vincristine—colon cancer	0.00365	0.00536	CcSEcCtD
Bimatoprost—Vision blurred—Fluorouracil—colon cancer	0.00358	0.00524	CcSEcCtD
Bimatoprost—Vertigo—Irinotecan—colon cancer	0.00356	0.00522	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Capecitabine—colon cancer	0.00354	0.00519	CcSEcCtD
Bimatoprost—Hypertension—Vincristine—colon cancer	0.00351	0.00515	CcSEcCtD
Bimatoprost—Visual disturbance—Methotrexate—colon cancer	0.00346	0.00507	CcSEcCtD
Bimatoprost—Cough—Irinotecan—colon cancer	0.00346	0.00507	CcSEcCtD
Bimatoprost—Hypertension—Irinotecan—colon cancer	0.00342	0.00502	CcSEcCtD
Bimatoprost—Depression—Capecitabine—colon cancer	0.00338	0.00496	CcSEcCtD
Bimatoprost—Infection—Vincristine—colon cancer	0.0033	0.00484	CcSEcCtD
Bimatoprost—Nervous system disorder—Vincristine—colon cancer	0.00326	0.00477	CcSEcCtD
Bimatoprost—Chest pain—Fluorouracil—colon cancer	0.00323	0.00474	CcSEcCtD
Bimatoprost—Infection—Irinotecan—colon cancer	0.00321	0.00471	CcSEcCtD
Bimatoprost—Nervous system disorder—Irinotecan—colon cancer	0.00317	0.00465	CcSEcCtD
Bimatoprost—Infection—Fluorouracil—colon cancer	0.00308	0.00451	CcSEcCtD
Bimatoprost—Rhinitis—Capecitabine—colon cancer	0.00305	0.00448	CcSEcCtD
Bimatoprost—Nervous system disorder—Fluorouracil—colon cancer	0.00304	0.00445	CcSEcCtD
Bimatoprost—Liver function test abnormal—Methotrexate—colon cancer	0.00303	0.00444	CcSEcCtD
Bimatoprost—Pharyngitis—Capecitabine—colon cancer	0.00302	0.00443	CcSEcCtD
Bimatoprost—Insomnia—Vincristine—colon cancer	0.003	0.0044	CcSEcCtD
Bimatoprost—Oedema peripheral—Capecitabine—colon cancer	0.003	0.0044	CcSEcCtD
Bimatoprost—Connective tissue disorder—Capecitabine—colon cancer	0.00299	0.00439	CcSEcCtD
Bimatoprost—Visual impairment—Capecitabine—colon cancer	0.00294	0.0043	CcSEcCtD
Bimatoprost—Insomnia—Irinotecan—colon cancer	0.00292	0.00429	CcSEcCtD
Bimatoprost—Dyspnoea—Irinotecan—colon cancer	0.00288	0.00423	CcSEcCtD
Bimatoprost—Somnolence—Irinotecan—colon cancer	0.00287	0.00422	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Vincristine—colon cancer	0.00287	0.0042	CcSEcCtD
Bimatoprost—Eye disorder—Capecitabine—colon cancer	0.00285	0.00417	CcSEcCtD
Bimatoprost—Dyspepsia—Irinotecan—colon cancer	0.00285	0.00417	CcSEcCtD
Bimatoprost—Pain—Vincristine—colon cancer	0.00284	0.00416	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—colon cancer	0.00283	0.00415	CcSEcCtD
Bimatoprost—Insomnia—Fluorouracil—colon cancer	0.0028	0.00411	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Irinotecan—colon cancer	0.00279	0.00409	CcSEcCtD
Bimatoprost—Pain—Irinotecan—colon cancer	0.00276	0.00405	CcSEcCtD
Bimatoprost—Angiopathy—Capecitabine—colon cancer	0.00276	0.00405	CcSEcCtD
Bimatoprost—Dyspnoea—Fluorouracil—colon cancer	0.00276	0.00405	CcSEcCtD
Bimatoprost—Somnolence—Fluorouracil—colon cancer	0.00275	0.00404	CcSEcCtD
Bimatoprost—Mediastinal disorder—Capecitabine—colon cancer	0.00275	0.00403	CcSEcCtD
Bimatoprost—Dyspepsia—Fluorouracil—colon cancer	0.00273	0.004	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00267	0.00392	CcSEcCtD
Bimatoprost—Erythema—Capecitabine—colon cancer	0.00265	0.00389	CcSEcCtD
Bimatoprost—Pain—Fluorouracil—colon cancer	0.00265	0.00388	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Methotrexate—colon cancer	0.00263	0.00386	CcSEcCtD
Bimatoprost—Depression—Methotrexate—colon cancer	0.00252	0.00369	CcSEcCtD
Bimatoprost—Vision blurred—Capecitabine—colon cancer	0.0025	0.00366	CcSEcCtD
Bimatoprost—Vertigo—Capecitabine—colon cancer	0.00238	0.00349	CcSEcCtD
Bimatoprost—Asthenia—Vincristine—colon cancer	0.00238	0.00349	CcSEcCtD
Bimatoprost—Palpitations—Capecitabine—colon cancer	0.00234	0.00344	CcSEcCtD
Bimatoprost—Asthenia—Irinotecan—colon cancer	0.00232	0.0034	CcSEcCtD
Bimatoprost—Cough—Capecitabine—colon cancer	0.00231	0.00339	CcSEcCtD
Bimatoprost—Hypertension—Capecitabine—colon cancer	0.00229	0.00336	CcSEcCtD
Bimatoprost—Chest pain—Capecitabine—colon cancer	0.00226	0.00331	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—colon cancer	0.00225	0.0033	CcSEcCtD
Bimatoprost—Anxiety—Capecitabine—colon cancer	0.00225	0.0033	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00224	0.00329	CcSEcCtD
Bimatoprost—Dry mouth—Capecitabine—colon cancer	0.00221	0.00324	CcSEcCtD
Bimatoprost—Dizziness—Vincristine—colon cancer	0.0022	0.00322	CcSEcCtD
Bimatoprost—Pruritus—Fluorouracil—colon cancer	0.00219	0.00321	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—colon cancer	0.00219	0.0032	CcSEcCtD
Bimatoprost—Infection—Capecitabine—colon cancer	0.00215	0.00315	CcSEcCtD
Bimatoprost—Dizziness—Irinotecan—colon cancer	0.00214	0.00314	CcSEcCtD
Bimatoprost—Nervous system disorder—Capecitabine—colon cancer	0.00212	0.00311	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—colon cancer	0.00212	0.00311	CcSEcCtD
Bimatoprost—Skin disorder—Capecitabine—colon cancer	0.0021	0.00308	CcSEcCtD
Bimatoprost—Rash—Vincristine—colon cancer	0.00209	0.00307	CcSEcCtD
Bimatoprost—Dermatitis—Vincristine—colon cancer	0.00209	0.00307	CcSEcCtD
Bimatoprost—Headache—Vincristine—colon cancer	0.00208	0.00305	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—colon cancer	0.00206	0.00302	CcSEcCtD
Bimatoprost—Dizziness—Fluorouracil—colon cancer	0.00205	0.003	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—colon cancer	0.00204	0.003	CcSEcCtD
Bimatoprost—Rash—Irinotecan—colon cancer	0.00204	0.00299	CcSEcCtD
Bimatoprost—Dermatitis—Irinotecan—colon cancer	0.00204	0.00299	CcSEcCtD
Bimatoprost—Headache—Irinotecan—colon cancer	0.00203	0.00297	CcSEcCtD
Bimatoprost—Erythema—Methotrexate—colon cancer	0.00197	0.00289	CcSEcCtD
Bimatoprost—Nausea—Vincristine—colon cancer	0.00197	0.00289	CcSEcCtD
Bimatoprost—Insomnia—Capecitabine—colon cancer	0.00196	0.00287	CcSEcCtD
Bimatoprost—Rash—Fluorouracil—colon cancer	0.00195	0.00286	CcSEcCtD
Bimatoprost—Dermatitis—Fluorouracil—colon cancer	0.00195	0.00286	CcSEcCtD
Bimatoprost—Headache—Fluorouracil—colon cancer	0.00194	0.00284	CcSEcCtD
Bimatoprost—Dyspnoea—Capecitabine—colon cancer	0.00193	0.00283	CcSEcCtD
Bimatoprost—Nausea—Irinotecan—colon cancer	0.00192	0.00282	CcSEcCtD
Bimatoprost—Dyspepsia—Capecitabine—colon cancer	0.0019	0.00279	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Capecitabine—colon cancer	0.00187	0.00274	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—colon cancer	0.00186	0.00273	CcSEcCtD
Bimatoprost—Pain—Capecitabine—colon cancer	0.00185	0.00271	CcSEcCtD
Bimatoprost—Nausea—Fluorouracil—colon cancer	0.00184	0.0027	CcSEcCtD
Bimatoprost—Vertigo—Methotrexate—colon cancer	0.00177	0.0026	CcSEcCtD
Bimatoprost—Cough—Methotrexate—colon cancer	0.00172	0.00253	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—colon cancer	0.00168	0.00246	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00167	0.00245	CcSEcCtD
Bimatoprost—Infection—Methotrexate—colon cancer	0.0016	0.00235	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—colon cancer	0.00158	0.00232	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—colon cancer	0.00156	0.00229	CcSEcCtD
Bimatoprost—Asthenia—Capecitabine—colon cancer	0.00155	0.00228	CcSEcCtD
Bimatoprost—Pruritus—Capecitabine—colon cancer	0.00153	0.00225	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—colon cancer	0.00146	0.00214	CcSEcCtD
Bimatoprost—Dyspnoea—Methotrexate—colon cancer	0.00144	0.00211	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—colon cancer	0.00143	0.0021	CcSEcCtD
Bimatoprost—Dizziness—Capecitabine—colon cancer	0.00143	0.0021	CcSEcCtD
Bimatoprost—Dyspepsia—Methotrexate—colon cancer	0.00142	0.00208	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—colon cancer	0.00139	0.00204	CcSEcCtD
Bimatoprost—Pain—Methotrexate—colon cancer	0.00138	0.00202	CcSEcCtD
Bimatoprost—Rash—Capecitabine—colon cancer	0.00136	0.002	CcSEcCtD
Bimatoprost—Dermatitis—Capecitabine—colon cancer	0.00136	0.002	CcSEcCtD
Bimatoprost—Headache—Capecitabine—colon cancer	0.00136	0.00199	CcSEcCtD
Bimatoprost—Nausea—Capecitabine—colon cancer	0.00129	0.00188	CcSEcCtD
Bimatoprost—Asthenia—Methotrexate—colon cancer	0.00116	0.00169	CcSEcCtD
Bimatoprost—Pruritus—Methotrexate—colon cancer	0.00114	0.00167	CcSEcCtD
Bimatoprost—Dizziness—Methotrexate—colon cancer	0.00107	0.00156	CcSEcCtD
Bimatoprost—Rash—Methotrexate—colon cancer	0.00102	0.00149	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—colon cancer	0.00101	0.00149	CcSEcCtD
Bimatoprost—Headache—Methotrexate—colon cancer	0.00101	0.00148	CcSEcCtD
Bimatoprost—Nausea—Methotrexate—colon cancer	0.000957	0.0014	CcSEcCtD
